Active and passive transport of drugs in the human placenta;Czynny i bierny transport leków w łożysku ludzkim

Ginekologia Polska

Volumn 80, Issue 10, 2009, Pages 772-777

  Włoch, Stanisław ^a   Pałasz, Artur ^a   Kamiński, Marcin ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Drug transport; Multidrug resistance protein; Placenta; Pregnancy; Syncytiotrophoblast

Indexed keywords

ABC TRANSPORTER; CYTOCHROME P450; DRUG; GLYCOPROTEIN P; XENOBIOTIC AGENT;

DRUG EFFECT; DRUG TOXICITY; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; METABOLISM; MICROVILLUS; PHYSIOLOGY; PLACENTA; PREGNANCY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CYTOCHROME P-450 ENZYME SYSTEM; DRUG TOXICITY; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; MICROVILLI; P-GLYCOPROTEINS; PHARMACEUTICAL PREPARATIONS; PLACENTA; PREGNANCY; XENOBIOTICS;

EID: 74049110927     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Briggs G, Freeman R, Yaffe S. Drugs in pregnancy and lactation: a reference quide to fetal and neonatal risk. 7th ed. Philadelphia, USA: Lippincott Williams and Wilkins, 2005.
2. Andrade S, Gurwitz J, Davis R, [et al.]. Prescription drug use in pregnancy. Am. J Obstet Gynecol. 2004, 191, 398.
3. Smith L, Dalrymple J, Leiserowitz G, [et al.]. Obstetrical deliveries associated with maternal malignancy in California. Am J Obstet Gynecol. 2001, 184, 1504-1513.
4. Evseenko D, Paxton J, Keelan J. Active transport across the human placenta: Impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol. 2006, 2, 51-69.
5. Chama C, Audu B, Kyari O. Prevention of mother-to-child transmission of HIV at Maiduguri, Nigeria. J Obstet Gynaecol. 2004, 24, 266269.
6. Shiverick K, Slikker S, Rogerson S, [et al.]. Drug and placenta - a workshop report. Placenta. 2003,24, suppl. A, 55-59.
7. Collier A, Tingle M, Paxton J, [et al.]. Metabolizing enzyme localization and activities in the firsttrimester human placenta: The effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod. 2002, 17, 2564-2572.
8. Włoch S. Monooksygenazy zależne od cytochromu P-450 oraz enzymy II fazy przemian ksenobiotyków w łożysku. Ann Acad Med Siles. 2009, 63, 78. [in Polish].
9. Mathias A, Hitti J, Unadkat J. P-glycoprotein expression in human placenta of various gestational ages. Am J Physiol. Regul Integr Comp Physiol. 2005, 289, R963R969.
10. Patel P, Weeraskekera N, Hitchins M, [et al.]. Semi-quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gen transcript in 1st and 3rd trimester human placenta. Placenta. 2003, 24, 39-44.
11. Syme M, Paxton J, Keelan J. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004, 43, 487-514.
12. Litman T, Druley T, Stein W, [et al.]. From MDR to MXR: New understanding of multi-drug resistance systems, their properties and clinical significance. Cell Mol Life Sci. 2001, 58, 931959.
13. Bodo A, Bakos E, Szeri F, [et al.]. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett. 2003,140-141, 133-143.
14. Smith A, Timmermans-Hereijgers J, Roelafsen B, [et al.]. The human MDR3 P-glycoprotein promotes of phosphatydylocholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 1994, 354, 263266.
15. Dixon P, Weerasekera N, Linton K, [et al.]. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy evidence for a defect in protein trafficking. Hum Molec Genet. 2000, 9, 1209-1217.
16. Pascolo L, Fernetti C, Pirulli D, [et al.]. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in Behio cells. Biochem Biophys Res Commun. 2003, 303, 259265.
17. St-Pierre M, Serrano M, Macias R, [et al.]. Expression on members of the multidrug resistance family in human term placenta. Am J Physiol Regul Integr Comp Physiol. 2000, 279, 1495- 1503.
18. Reid G, Wielinga O, Zelcer N, [et al.]. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA. 2003, 100, 9244-9249.
19. Yabuuchi H, Takayanagi S, Yoshinaga K, [et al.]. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem Biophys Res Commun. 2002, 299, 410-417.
20. Schuurhuis G, Broxterman H, De Lange J, [et al.]. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer. 1991, 64, 857-861.
21. Langmann T, Mauerer R, Zahn A, [et al.]. Real-time reverse transcription - PCR expression profiling of the complete ATP-binding cassette transporter. Clin Chem. 2003, 49, 230-238.
22. Jonker J, Smit J, Brinkhuis M, [et al.]. Role of breast cancer resistance protein in the bioavaibility and fetal penetration of topotecan. J Natl Cancer Inst. 2000, 92, 16511656.
23. Sweet D. Organic anion transporter (SLC22a) family members as mediators of toxicity. Toxicol Appl Pharmacol. 2005, 204, 198-215.
24. Cha S, Sekine T, Kusuhara H, [et al.]. Molecular cloning and characterization of multispecific ogranic anion transporter 4 expressed in the placenta. J Biol Chem. 2000, 275, 4507-4512.
25. Ugele B, St-Pierre M, Pihusch M, [et al.]. Characterization and identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol Metab. 2003, 284, E390-E398.
26. Sato K, Sugawara J, Sato T, [et al.]. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta. 2003, 24, 144-148.
27. St-Pierre M, Hagenbuch B, Ugele B, [et al.]. Characterization of an organic anion - transporting polypeptide (OATP-B) in human placenta. J Clin Endocrinol Metab. 2002 87, 1856-1863.
28. Briz O, Serrano M, Macjas R, [et al.]. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta - maternal liver tandem excretory pathway for foetal bilirubin. Biochem J. 2003, 371, 897-905.
29. Grube M, Schwabedissen H, Draber K, [et al.]. Expression, localization and function of the carnitine transporter OCTN2(Slc22a5) in human placenta. Drug Metab Dispos. 2005, 33, 31- 37.
30. Ganapathy V, Prasad P, Ganapathy M, [et al.]. Placental transporters relevant to drug distribution across the maternal-fetal interface. J Pharmacol Exp Ther. 2000, 294, 413-420.
31. Baldwin S, Yao S, Hyder R, [et al.]. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem. 2005, 280, 15880-15887.
32. Barros L, Yudilevich D, Jarvis S, [et al.]. Immunolocalization of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms. Pflugers Arch. 1995, 429, 394-399.